MAPT and Alzheimer disease: In 3xTg-AD mice, i.e., an animal model of AD exhibiting age-dependent β-amyloid and tau pathologies, chronic administration of um-PEA reduced brain levels of several pro-inflammatory mediators and showed neuroprotective effects [142,187,240,248].